When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
CRNX - Crinetics: An Orphan Disease Innovator On The Rise
Crinetics Pharmaceuticals Inc.
As a potential big winner, Crinetics Pharmaceuticals executes prudent corporate strategies that focus on orphan diseases and established biological pathways.
The lead medicine (paltusotine) demonstrated strong efficacy in its Phase 2 (ACROBAT Edge) trial for acromegaly.
I expect superb data release for the Phase 3 (PATHFNDR 1& 2) study in 2023.